GGrantIndex
← Leaderboards

Michael R Zile

Ralph H Johnson Va Medical Center

$4,310,919
Attributed
$4,310,919
Total exposure
11
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $494.2K · FY200725
$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,310,919 · 7
VA$0 · 4

By mechanism

P01$1,848,142 · 3
R01$1,784,544 · 2
R56$386,825 · 1
S10$291,408 · 1
I01$0 · 4

Top collaborators

Most similar at Ralph H Johnson Va Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Myocardial

Research focus

MyocardialMolecularMyocardiumChronicCollagenProteinsHypertensionHealthcareFibroblastsPressureExtracellular MatrixIn VivoLeadIn VitroPlayClinically RelevantPreventHeart FailureCardiacEfracPropertyInterstitialBiopsyPhenotype

Grant awards (27)

Cellular Mechanisms of Cardiac ECM Structure and Function$0
I01 · FY2025 · VA
Cellular Mechanisms of Cardiac ECM Structure and Function$0
I01 · FY2024 · VA
Cellular Mechanisms of Cardiac ECM Structure and Function$0
I01 · FY2023 · VA
Macrophage Expression of SPARC Contributes to Pressure-Overload Dependent Change in Collagen Content and Myocardial Stiffness$0
I01 · FY2021 · VA
Macrophage Expression of SPARC Contributes to Pressure-Overload Dependent Change in Collagen Content and Myocardial Stiffness$0
I01 · FY2020 · VA
Macrophage Expression of SPARC Contributes to Pressure-Overload Dependent Change in Collagen Content and Myocardial Stiffness$0
I01 · FY2019 · VA
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure$375,150
R01 · FY2018 · HL · contact PI
Macrophage Expression of SPARC Contributes to Pressure-Overload Dependent Change in Collagen Content and Myocardial Stiffness$0
I01 · FY2018 · VA
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure$375,150
R01 · FY2017 · HL · contact PI
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure$374,975
R01 · FY2016 · HL · contact PI
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure$387,175
R01 · FY2015 · HL · contact PI
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure$386,825
R56 · FY2014 · HL · contact PI
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure$0
I01 · FY2014 · VA · contact PI
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure$0
I01 · FY2013 · VA · contact PI
Connexin Distribution in Physiological Versus Pathological Cardiac Hypertrophy$0
I01 · FY2013 · VA · contact PI
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure$0
I01 · FY2012 · VA · contact PI
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure$0
I01 · FY2011 · VA · contact PI
DIASTOLIC HEART FAILURE: DEFINING CARDIOCYTE MECHANISMS$269,399
P01 · FY2007 · HL · contact PI
CORE--ANIMAL MODEL$224,781
P01 · FY2007 · HL · contact PI
DIASTOLIC HEART FAILURE: DEFINING CARDIOCYTE MECHANISMS$161,541
P01 · FY2003 · HL
CORE-- MODEL$134,786
P01 · FY2003 · HL
MECHANISMS FOR LOAD INDUCTION OF HYPERTROPHY$290,033
P01 · FY2002 · HL
HIGH RESOLUTION ECHOCARDIOGRAPHY SYSTEM$291,408
S10 · FY2001 · RR
MECHANISMS FOR LOAD INDUCTION OF HYPERTROPHY$290,033
P01 · FY2001 · HL
MECHANISMS FOR LOAD INDUCTION OF HYPERTROPHY$290,033
P01 · FY2000 · HL
STIFFNESS IN HYPERTROPHY-ROLE OF CARDIOCYTE CYTOSKELETON$272,094
R01 · FY2000 · HL
MECHANISMS FOR LOAD INDUCTION OF HYPERTROPHY$187,536
P01 · FY2000 · HL